Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03416335
Title A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc

lung non-small cell carcinoma

stomach cancer


cervical cancer

hepatocellular carcinoma

Advanced Solid Tumor

Merkel cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma



DSP-0509 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.